U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07227831) titled 'A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer' on Nov. 05.
Brief Summary: The goal of this clinical trial is to learn if the TheraBionic P1 device given to patients with advanced or metastatic HR positive, HER2 negative breast cancer who have progressed on standard of care options can affect patients survival. The main questions it aims to answer are:
* will the TheraBionic P1 device affect progression free and overall survival in advanced or metastatic HR positive, HER2 negative breast cancer
* the long term safety and tolerability of the TheraBionic P1 device
* assessment of how the ...